Medicare Enrolled

Dr. Ashleigh Porter

Hematology & Oncology · Cedar Park, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1401 MEDICAL PKWY STE 200, Cedar Park, TX 78613
5122606050
In practice since 2015 (10 years)
NPI: 1326435371 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Porter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Porter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Porter

Dr. Ashleigh Porter is a hematology & oncology in Cedar Park, TX, with 10 years in practice. Based on federal Medicare data, Dr. Porter performed 38,690 Medicare services across 1,506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Porter received a total of $1,144 from 24 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Porter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 25% volume in TX$ $1,144 industry payments

Medicare Practice Summary

Medicare Utilization ↗
38,690
Medicare services
Top 25% in TX for hematology & oncology
1,506
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,869 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)22,500$0$2
Darbepoetin injection (Aranesp) for anemia6,610$2$20
Pembrolizumab injection (Keytruda)4,700$43$137
Dexamethasone injection (steroid)948$0$1
Anti-nausea injection (Aloxi/palonosetron)550$1$114
Blood draw (venipuncture)540$8$20
Complete blood count (CBC) with differential450$8$36
Office visit, established patient, complex (40-54 min)265$123$496
Office visit, established patient (30-39 min)233$84$368
Injection, granisetron hydrochloride, 100 mcg190$0$24
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less149$44$313
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less142$20$157
Immunoglobulin level test141$9$56
Administration of chemotherapy into vein, 1 hour or less122$92$707
Measurement of immunoglobulin light chains94$17$60
Drug injection, under skin or into muscle93$10$96
Injection, zoledronic acid, 1 mg90$7$431
Microscopic examination for white blood cells with manual cell count88$4$22
Complete blood count (CBC), automated88$6$34
Infusion, normal saline solution , 1000 cc77$2$19
New patient office visit, complex (60-74 min)54$147$709
Infusion into a vein for hydration, each additional hour48$9$75
Injection of additional new drug or substance into vein48$11$108
Administration of chemotherapy into vein, each additional hour46$20$161
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-342$20$128
Irrigation of implanted venous access drug delivery device37$18$114
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour33$15$100
Office visit, established patient (20-29 min)32$60$250
Administration of additional new drug or substance into vein, 1 hour or less31$45$344
Infusion into a vein for hydration, 31-60 minutes29$22$256
Vitamin B-12 level test28$15$76
Folic acid level test28$14$73
Drawing of blood for a medical problem28$60$264
Carcinoembryonic antigen (cea) protein level25$19$99
Unclassified drugs25$1$8
Protein measurement, serum24$11$98
Immunologic analysis technique on serum24$29$108
Immunologic analysis technique on serum (immunofixation)24$22$160
New patient office visit (45-59 min)14$96$565
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
92.8% medium
6.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,144
Total received (2021-2024)
Avg $286/year across 4 years
Bottom 32% in TX for hematology & oncology
24
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,144 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$364
2023
$310
2022
$380
2021
$91

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$217
Merck Sharp & Dohme LLC
$109
Astellas Pharma US Inc
$81
Celgene Corporation
$75
E.R. Squibb & Sons, L.L.C.
$73
Janssen Biotech, Inc.
$73
ABBVIE INC.
$70
AstraZeneca Pharmaceuticals LP
$68
Eisai Inc.
$49
Adaptive Biotechnologies Corporation
$37
Amgen Inc.
$36
Lilly USA, LLC
$32
PFIZER INC.
$32
Seagen Inc.
$27
Pharmacyclics LLC, An AbbVie Company
$20
GlaxoSmithKline, LLC.
$20
Secura Bio, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$19
TerSera Therapeutics LLC
$18
Alexion Pharmaceuticals, Inc.
$15
MorphoSys, US Inc.
$14
GENZYME CORPORATION
$13
Tactile Systems Technology Inc
$13
Genentech USA, Inc.
$13
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
CALQUENCE · COPIKTRA · ERLEADA · Fabhalta · Flexitouch Plus · IBRANCE · IMBRUVICA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PROMACTA · REBLOZYL · TAGRISSO · TECVAYLI · TUKYSA · ULTOMIRIS · VENCLEXTA · VERZENIO · XTANDI · Xermelo · Xospata · Xtandi · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a hematology & oncology in Cedar Park?
Compare hematology & oncologys in the Cedar Park area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
32
Per 100K population
5.0
County median income
$108,309
Nearest hospital
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Porter is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Porter experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Porter performed 22,500 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Porter receive payments from pharmaceutical companies?
Yes. Dr. Porter received a total of $1,144 from 24 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Porter's costs compare to other hematology & oncologys in Cedar Park?
Dr. Porter's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Porter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →